Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
NEW YORK, NY – January 26, 2016 -- InvestorsHub NewsWire -- Aluf Holdings, Inc. (OTCBB: AHIX) is a holding company that operates growth-oriented, proprietary software businesses...
Axxess Pharma's All-Natural Tapout Products Now Available in Large North American Fitness Chain Successful Pilot Program to Lead to Tapout Products in all 300 Plus Fitness Centers Across North...
Axxess Pharma Signs Major Manufacturing, Marketing and Distribution Agreement with Chinese Manufacturer Management Projects 5 Year Agreement to Generate Additional $525,000 USD in First Year...
Axxess Pharma Provides Shareholder Update Management Files Year Ending 2014 Financials PR Newswire TORONTO, April 15, 2015 TORONTO, April 15, 2015 /PRNewswire/ -- Axxess Pharma Inc. (OTC: AXXE) a...
Axxess Pharma Receives US Food and Drug Administration (FDA) Approval to Sell Omega-3 Fish Oil, Muscle Growth, Muscle Recovery Supplements and Turbo Blend Protein Powder Management Projecting...
BELFAST, IE - February 23, 2015 - InvestorsHub NewsWire TheStockRadio.com is widely recognized for bringing the small-cap investing community a solid source for fund managers, angel...
TORONTO, June 24, 2014 (GLOBE NEWSWIRE) -- Revive BioScience Ltd. has rescinded the asset purchase agreement for the company's TapOut brand of products and related patents with Axxess Pharma Inc...
AUSTIN, Texas, July 17, 2013 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. announced today that a new audio interview with Axxess Pharma, Inc. (Pink Sheets:AXXE), is now available. The interview...
Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com PR Newswire MARKHAM, Ontario, June 4, 2013 MARKHAM, Ontario, June 4, 2013 /PRNewswire/ -- Axxess Pharma Inc. (OTC Pink: AXXE), a...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
